如要提出意见建议,请到社区论坛发帖反馈。

约有284篇,以下是第21-30 排序:相关性|最多阅读|最新上传

30 Pages
Parallel experimental design and multivariate analysis provides efficient screening of cell culture media supplements to improve biosimilar product quality
37 Pages
clinical similarity of the biosimilar abp 501 compared with adalimumab after single transition long-term results from a randomised, double-blind, 5
clinical similarity of the biosimilar abp 501 compared with adalimumab after single transition long-term results from a randomised, double-blind, 5
  • 0
  • 崔亚杰 2017-08-04 14:52
  • 热度: 格式: pdf
34 Pages
efficacy and safety of biosimilar (sar342434 insulin lispro) in adults with type 1 diabetes also using insulin glargine-sorella 1 study.[2017][diab
efficacy and safety of biosimilar (sar342434 insulin lispro) in adults with type 1 diabetes also using insulin glargine-sorella 1 study.[2017][diab
  • 0
  • ccyyjjie 2017-08-02 02:04
  • 热度: 格式: pdf
39 Pages
nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (basaglar(r)abasaglar(r)) approved in the european un
nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (basaglar(r)abasaglar(r)) approved in the european un
  • 0
  • cyjdoctor 2017-05-24 17:07
  • 热度: 格式: pdf
97 Pages
Development of Biopharmaceuticals and Biosimilar Drug Delivery(PPT-97)
文档标题《Development of Biopharmaceuticals and Biosimilar Drug Delivery》,总页数为97页,主要介绍了与<Development of Biopharmaceuticals and Biosimilar Drug Delivery>相关的资料,希望对大家有用,欢迎大家浏...
  • 0
  • 4dddc75b 2015-03-30 22:38
  • 热度: 格式: ppt
13 Pages
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylo
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylo
  • 0
  • febday 2020-03-01 23:03
  • 热度: 格式: pdf
11 Pages
a randomized, double-blind, efficacy and safety study of pf-05280586 (a rituximab biosimilar) compared with rituximab reference product (mabthera((
a randomized, double-blind, efficacy and safety study of pf-05280586 (a rituximab biosimilar) compared with rituximab reference product (mabthera((
  • 0
  • 316072725c 2020-03-19 14:15
  • 热度: 格式: pdf
12 Pages
a multicenter, retrospective study (re-enact 2) on the use of razumab (world´s first biosimilar ranibizumab) in wet age-related macular degeneratio
a multicenter, retrospective study (re-enact 2) on the use of razumab (world´s first biosimilar ranibizumab) in wet age-related macular degeneratio
  • 0
  • 163667721 2020-03-19 14:10
  • 热度: 格式: pdf
13 Pages
population pharmacokinetic modeling of pf-06439535 (a bevacizumab biosimilar) and reference bevacizumab (avastin((r))) in patients with advanced no
population pharmacokinetic modeling of pf-06439535 (a bevacizumab biosimilar) and reference bevacizumab (avastin((r))) in patients with advanced no...
  • 0
  • ccyyjjie 2020-03-14 01:52
  • 热度: 格式: pdf
10 Pages
the path towards a tailored clinical biosimilar development.[2020][biodrugs]
the path towards a tailored clinical biosimilar development.[2020][biodrugs]

向豆丁求助:有没有biosimilar?